Skip to main content

Table 1 Clinical and demographic characteristics of patients with or without postoperative hypotension

From: Predictive value of estimated plasma volume for postoperative hypotension in percutaneous intramyocardial septal radiofrequency ablation treating for hypertrophic obstructive cardiomyopathy

 

Missing

n (%)

Patients with POH

(N=53)

Patients without POH (N=352)

P Value

Sex, Male

0

22 (41.5)

233 (66.2)

0.001

Age, year

0

49 (37 ~ 61)

49 (40 ~ 57)

0.987

BMI, kg/m2

0

23.56 (20.83 ~ 25.39)

25.65 (23.33 ~ 28.08)

<0.001

Diabetes Mellitus

0

3 (5.7)

23 (6.5)

>0.999

Hypertension

0

9 (17.0)

122 (34.7)

0.010

Coronary Heart Disease

6 (1.5)

4 (7.5)

41 (11.8)

0.491

Family History of HCM

0

15 (28.3)

89 (25.3)

0.639

Family History of SCD

0

10 (18.9)

38 (10.8)

0.090

ACEI or ARB

0

6 (11.3)

76 (21.6)

0.083

β-blocker

0

50 (94.3)

336 (95.5)

0.992

CCB

0

7 (13.2)

73 (20.7)

0.199

Diuretics

3 (0.7)

4 (7.5)

26 (7.4)

>0.999

Prior SRT

0

4 (7.5)

13 (3.7)

0.349

Syncope or presyncope

0

34 (64.2)

129 (36.6)

<0.001

NYHA III to IV

0

36 (67.9)

207 (58.8)

0.207

  1. Categorical variables were measured with count (percentage) and numerical variables were measured with median (interquartile range)
  2. BMI Body mass index, HCM Hypertrophic cardiomyopathy, SCD Sudden cardiac death, ACEI Angiotensin converting enzyme inhibitor, ARB Angiotensin receptor blocker, CCB Calcium channel blocker, SRT Septal reduction therapy, NYHA New York Heart Association, SRT Septal reduction therapy